Baxter Announces U.S. FDA Clearance of Altapore Shape ... | 合法醫療器材資訊網

2020年7月9日—AltaporeShapeisanimplantintendedtofillbonyvoidsorgapsoftheskeletalsystem(i.e.,extremities,posterolateralspineandpelvis).Altapore ...

PDF[1]

DEERFIELD, Ill. - 2020-07-09

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced U.S. Food and Drug Administration (FDA) clearance of Altapore Shape Bioactive Bone Graft, the latest addition to the company’s next-generation bone graft substitute product line. Altapore Shape is designed to enhance bone growth and help achieve fusion, which can lead to reduced pain and other improved clinical outcomes for patients.

“We are introducing this new format in our Altapore product line to give surgeons versatile tools as they work to advance the art of healing and improve clinical outcomes in the operating room,” said Wil Boren, president of Baxter’s Advanced Surgery business. 

A 2019 prospective, open-label, non-randomized clinical study evaluated 102 patients with degenerative disc ...